# Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.

> **NCT07195864** · — · RECRUITING · sponsor: **SIFI SpA** · enrollment: 24 (estimated)

## Conditions studied

- Acanthamoeba Keratitis

## Interventions

- **DRUG:** PHMB 0.08%

## Key facts

- **NCT ID:** NCT07195864
- **Lead sponsor:** SIFI SpA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-30
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07195864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07195864, "Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07195864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*